<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Mycobacterium tuberculosis on Mycobacterial Infection Research Unit</title>
    <link>https://miru-ffm.org/tags/mycobacterium-tuberculosis/</link>
    <description>Recent content in Mycobacterium tuberculosis on Mycobacterial Infection Research Unit</description>
    <generator>Source Themes academia (https://sourcethemes.com/academic/)</generator>
    <language>en-us</language>
    <copyright>Copyright &amp;copy; {year}</copyright>
    <lastBuildDate>Sun, 15 Dec 2024 00:00:00 +0000</lastBuildDate>
    
	    <atom:link href="https://miru-ffm.org/tags/mycobacterium-tuberculosis/index.xml" rel="self" type="application/rss+xml" />
    
    
    <item>
      <title>New publication in Clinical Microbiology and Infection</title>
      <link>https://miru-ffm.org/news/post7/</link>
      <pubDate>Sun, 15 Dec 2024 00:00:00 +0000</pubDate>
      
      <guid>https://miru-ffm.org/news/post7/</guid>
      <description>&lt;img src=&#34;featured2.jpg&#34;&gt;
&lt;br&gt;
Are &lt;i&gt;Mycobacterium tuberculosis&lt;/i&gt; complex lineages predictors for extrapulmonary tuberculosis?
&lt;br&gt;&lt;br&gt;
In our recent work, geographical origin and other host
determined factors such as female sex and age were stronger
predictors of extrapulmonary tuberculosis than Mtbc lineage.
&lt;br&gt;&lt;br&gt;
We are very happy to see this great collaboration between the Municipial Health Authorities (Gesundheitsamt) Frankfurt, the Research Center Borstel, the European Centres for Disease Control and Prevention (ECDC), Labor Dr. Limbach, and the University Hospital Frankfurt now published in CMI.
&lt;br&gt;&lt;br&gt;
You can find the paper here, at 
&lt;a href=&#34;https://miru-ffm.org/publication/cmi_2024&#34;&gt;miru-ffm.org&lt;/a&gt;, &lt;a href=&#34;https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(24)00535-4/fulltext&#34;&gt; the journal&#39;s homepage&lt;/a&gt;, or at &lt;a href=&#34;https://pubmed.ncbi.nlm.nih.gov/39528087/&#34;&gt;PubMed&lt;/a&gt;.
</description>
    </item>
    
    <item>
      <title>New publication in Infection</title>
      <link>https://miru-ffm.org/news/post6/</link>
      <pubDate>Mon, 18 Nov 2024 00:00:00 +0000</pubDate>
      
      <guid>https://miru-ffm.org/news/post6/</guid>
      <description>&lt;img src=&#34;figure_2.jpg&#34;&gt;
&lt;br&gt;
Drug-sensitive TB (DS-TB) is treated with isoniazid, rifampicin, ethambutol, and pyrazinamide. Factors like fast-metabolizing enzymes, malabsorption, and drug interactions can influence serum drug levels. Current TB treatment guidelines recommend weight-adapted dosing without considering sex differences. 
&lt;br&gt;&lt;br&gt;
In this study, we examine drug levels of isoniazid and rifampicin in TB patients treated between 2019 and 2023 at our center focusing on sex-specific aspects.
&lt;br&gt;&lt;br&gt;
Interestingly, rifampicin levels were significantly lower in men compared to women, despite weight-adjusted dosing. 
&lt;br&gt;&lt;br&gt;
You can find the paper here, at 
&lt;a href=&#34;https://miru-ffm.org/publication/infection_2024&#34;&gt;miru-ffm.org&lt;/a&gt;, &lt;a href=&#34;https://link.springer.com/article/10.1007/s15010-024-02424-5&#34;&gt; the journal&#39;s homepage&lt;/a&gt;, or at &lt;a href=&#34;https://pubmed.ncbi.nlm.nih.gov/39531129/&#34;&gt;PubMed&lt;/a&gt;.
</description>
    </item>
    
    <item>
      <title>Sex-dependent variability of isoniazid and rifampicin serum levels in patients with tuberculosis</title>
      <link>https://miru-ffm.org/publication/infection_2024/</link>
      <pubDate>Fri, 01 Nov 2024 00:00:00 +0000</pubDate>
      
      <guid>https://miru-ffm.org/publication/infection_2024/</guid>
      <description>&lt;p&gt;&lt;a href=&#34;https://link.springer.com/article/10.1007/s15010-024-02424-5&#34;&gt;At Springer&lt;/a&gt;
or
&lt;a href=&#34;https://pubmed.ncbi.nlm.nih.gov/39531129/&#34;&gt;Pubmed&lt;/a&gt;&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Extracorporeal membrane oxygenation (ECMO) in patients with tuberculosis: systematic review and meta-analysis of 43 cases</title>
      <link>https://miru-ffm.org/publication/bmc_pulm_2024/</link>
      <pubDate>Mon, 22 Jan 2024 00:00:00 +0000</pubDate>
      
      <guid>https://miru-ffm.org/publication/bmc_pulm_2024/</guid>
      <description>&lt;p&gt;&lt;a href=&#34;https://bmcpulmmed.biomedcentral.com/articles/10.1186/s12890-023-02715-x&#34;&gt;At Journal homepage&lt;/a&gt;
or
&lt;a href=&#34;https://pubmed.ncbi.nlm.nih.gov/38254072/&#34;&gt;Pubmed&lt;/a&gt;&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Occurrence of extrapulmonary tuberculosis is associated with geographical origin: spatial characteristics of the Frankfurt TB cohort 2013-2018</title>
      <link>https://miru-ffm.org/publication/infection_2022/</link>
      <pubDate>Sat, 01 Oct 2022 00:00:00 +0000</pubDate>
      
      <guid>https://miru-ffm.org/publication/infection_2022/</guid>
      <description>&lt;p&gt;&lt;a href=&#34;https://link.springer.com/article/10.1007/s15010-022-01921-9&#34;&gt;At Springer&lt;/a&gt;
or
&lt;a href=&#34;https://pubmed.ncbi.nlm.nih.gov/36181634/&#34;&gt;Pubmed&lt;/a&gt;&lt;/p&gt;
</description>
    </item>
    
  </channel>
</rss>
